Download Pharmacy Curriculum Draft (NCRC); 2011

More documents

Recommendations

Info

clinical trials, Types of trials, Choice of patients, Exclusion of patientsand Monitoring a clinical trial.4. EMERGENCY TREATMENT.5. DRUG INTERACTIONS: Mechanism, Physiological factors affectinginteraction, Types and level of drug interactions, Role of pharmacist inevaluating drug interactions & its management.6. PHARMACOVIGILANCEa) Scope, definition and aims of Pharmacovigilanceb) Adverse Drug Reactions and Side Effects: Classification, Excessivepharmacological response, Idiosyncrasy, Secondary pharmacological effects,Allergic drug reactions, General toxicity, Toxicity following drugwithdrawal, Detection, Management of ADR, reporting of ADR in light ofinternational health monitoring system.7. PHARMACOTHERAPY PLANI. Develop, Implement, and Monitor Drug Therapy PlansA. Establish desired therapeutic outcomes.B. Consider drug and non-drug therapy alternatives.C. Develop drug therapy plans that are patient-specific, comprehensive,logical, practical, consider current evidence-based medicinerecommendations, include strategies for prevention, and include patienteducation.D. Establish a plan for therapeutic drug monitoring that includes accuratedocumentation of population and patient-specific parameters, dosinghistory/administration times, monitoring parameters, and daily SOAPnotes/plans.E. Develop and implement the pharmacotherapeutic plan promptly,efficiently,accurately, and effectively.F. Use an effective patient monitoring system (monitoring forms).G. Monitor the patient and follow up at appropriate intervals.H. Revise drug therapy plans on an ongoing basis.150 | Pakistan Pharmacist Federation; www.pharmacistfed.pk,www.pharmafed.wordpress.com, www.pharmarev.com, info@pharmacistfed.pk,
I. Ensure continuity of pharmaceutical care to and from the acute andambulatory care patient care settings.II. Pharmacotherapy Decision-Making –A. Pursue the role of drug therapy practitioner over that of drug therapyadvisor.B. Participate in pharmacotherapy decision-making by:i. Identifying opportunities for decision-making.ii. Proactively engaging decision-making opportunities.iii. Formulating decision rationale that is the result of rigorous inquiry,scientific reasoning, and evidence.iv. Pursuing the highest levels of decision-making.v. Seeking independence in making decisions and accepting personalresponsibility for the outcomes to patients resulting from one’s decisions.vi. Personally enacting decisions8. DRUG INDUCED DISEASES9. UTILIZATION OF CLINICAL DRUG LITERATURE: Introduction,Drug literature selection, Drug literature evaluation and Drug literaturecommunication.10. ONLINE PHARMACEUTICAL CARE SERVICES ANDGLOBALIZATION.11. PROVISION OF PHARMACEUTICAL CARE IN MULTIPLEENVIRONMENTS: Professionalism, physical assessment, bodysubstance precautions and the relationships between culture, race andgender to pharmaceutical care.PHARMACY PRACTICE-IV (CLINICAL PHARMACY-I) (PRACTICAL)Paper 6100 Marks• Clerkship in the Clinical Setting. A report related to Clinical <strong>Pharmacy</strong>Practices will be completed by the students and will be evaluated by theexternal examiner.151 | Pakistan Pharmacist Federation; www.pharmacistfed.pk,www.pharmafed.wordpress.com, www.pharmarev.com, info@pharmacistfed.pk,
Page 1 and 2:
NATIONAL CURRICULUM REVISIONCOMMITT
Page 5 and 6:
The aims and objectives of Doctor o
Page 7 and 8:
14. To prepare pharmacy graduates f
Page 9 and 10:
and its Applications in Pharmacy)[L
Page 11 and 12:
DETAILS OF COURSES ( SEMESTER SYSTE
Page 13 and 14:
PHARM 311 PHARMACEUTICS-I (Physical
Page 15 and 16:
9. Naser-ud-Din, Introduction to St
Page 17 and 18:
Expression of Genetic Information,
Page 19 and 20:
2. STRUCTURE OF CELL: Cell Membrane
Page 21 and 22:
Communications SkillsObjectives: En
Page 23 and 24:
Experiments to demonstrate some of
Page 25 and 26:
1990.9. Naser-ud-Din, Introduction
Page 27 and 28:
Hemorrhage and Other Causes of Hypo
Page 29 and 30:
IS 402ISLAMIC STUDIESCr. Hr.: 01 Ma
Page 31 and 32:
Publications New Delhi (1989)9) Dr.
Page 33 and 34:
PHARM 413 PHARMACEUTICS-V (Pharmace
Page 35 and 36:
e. Drug treatment of chronic inflam
Page 37 and 38:
j. Labiatae Peppermint, Thyme, Spea
Page 39 and 40:
SECOND SEMESTERPS 403PAKISTAN STUDI
Page 41 and 42:
NOTE:- Practicals of the subject sh
Page 43 and 44:
i. Drugs used for cough (Anti-tussi
Page 45 and 46:
1. Drugs of Animal OriginGeneral in
Page 47 and 48:
Frequency Table, Diagrams, Pictogra
Page 49 and 50:
pharmaceutical students Churchill L
Page 51 and 52:
anaesthetic drugs on human and the
Page 53 and 54:
5. Plant SteroidsIntroduction, extr
Page 55 and 56:
Adenoma, Chondroma, Fibroma, Leomyo
Page 57 and 58:
Aluminium Hydroxide, Ammonium Chlor
Page 59 and 60:
of frog. To demonstrate the effects
Page 61 and 62:
6. Tumor Inhibitors from PlantsIntr
Page 63 and 64:
• Components of a Computer• Com
Page 65 and 66:
1. INTRODUCTION(a) Role of Pharmaci
Page 67 and 68:
withdrawal, Detection, Management o
Page 69 and 70:
(Note: A minimum of 10 practicals w
Page 71 and 72:
14. Ronald D Schoenwald, Pharmacoki
Page 73 and 74:
Distribution, Relationship between
Page 75 and 76:
4. A J Winfield, Pharmaceutical Pra
Page 77 and 78:
. Factors: persistent, accumulation
Page 79 and 80:
vaccines.5. MISCELLANEOUS DETERMINA
Page 81 and 82:
3. T V Ramabhadran, Pharmaceutical
Page 83 and 84:
1. R Z Hussain, The Manual of Drug
Page 85 and 86:
NOTE:- Practical of the subject sha
Page 87 and 88:
PHARM 722 PHARMACY PRACTICE-XIII (C
Page 89 and 90:
3. The Pharmacy Act 1967.4. The Poi
Page 91 and 92:
6. Block, Roche, Soine and Wilson.
Page 93 and 94:
PHARM-D FIVE-YEAR COURSESCHEME OF S
Page 95 and 96:
Paper 4 Pharmacy Practice -VI (Fore
Page 97 and 98:
9. PREPARATION AND PROPERTIES OF HE
Page 99 and 100: c. Proteins and Amino acids: Brief
Page 101 and 102: 3. PHYSICO-CHEMICAL PRINCIPLES:a. S
Page 103 and 104: 2. Cooper and Gunns Tutorial Pharma
Page 105 and 106: Experiences, Motivation and Emotion
Page 107 and 108: 5. CENTRAL NERVOUS SYSTEM: Nerve Mu
Page 109 and 110: (b)Spinal Cord — Meninges (C.S.F.
Page 111 and 112: 1. DESCRIPTION OF STATISTICS: Descr
Page 113 and 114: Part: B, (Communications Skills)Obj
Page 115 and 116: 1. Writing. Advanced by Ron White.
Page 117 and 118: effervescent, granulated salts. Har
Page 119 and 120: Parasympathetic antagonists.f. Gang
Page 121 and 122: (Note: A minimum of 20 practicals w
Page 123 and 124: Sources, structure, preparation, de
Page 125 and 126: Microbiology with special reference
Page 127 and 128: Objectives• Develop vision of his
Page 129 and 130: 2 To enhance understanding of the s
Page 131 and 132: 1) Basic Concepts of Islam & Scienc
Page 133 and 134: Chondroma, Fibroma, Leomyoma, Neofi
Page 135 and 136: Note:(a)(b)(c)(d)Pollution and its
Page 137 and 138: 14. Pharmacology by Ran & Dell, 6 t
Page 139 and 140: (e) Phenolic volatile oils: Clove,
Page 141 and 142: their identification. Isolation and
Page 143 and 144: 6. ROLE OF PHARMACIST: As Public He
Page 145 and 146: d. I.R. Spectroscopye. Mass Spectro
Page 147 and 148: F O U R T H P R O F E S S I O N A L
Page 149: 16. NUCLEAR PHARMACY.17. THE PHYSIC
Page 153 and 154: 1. MASS TRANSFER.2. HEAT TRANSFER.3
Page 155 and 156: Delhi, 1986.4. Remington’s Pharma
Page 157 and 158: 14. IN-VITRO-IN-VIVO CORRELATION (I
Page 159 and 160: 5. QUALITY CONTROL OF STERILE PRODU
Page 161 and 162: F I N A L P R O F E S S I O N A LPH
Page 163 and 164: 3. Tyagi, Textbook of Synthetic Dru
Page 165 and 166: Horwood Publishing limited, West Su
Page 167 and 168: NOTE:- Practical of the subject sha
Page 169 and 170: 3. The Pharmacy Act 1967.4. The Poi
Page 171 and 172: 5. Application of Computers in Hosp
Page 173: RecommendationsAll members of NCRC
show all

Download Pharmacy Curriculum Draft (NCRC); 2011

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?